Molecular Formula | C6H11NO2 |
Molar Mass | 129.16 |
Density | 1.1426 (rough estimate) |
Melting Point | 320 °C (dec.) (lit.) |
Boling Point | 239.22°C (rough estimate) |
Flash Point | 108.7°C |
Water Solubility | 5 g/100 mL |
Vapor Presure | 0.00481mmHg at 25°C |
Appearance | Solid |
Color | White to beige |
Merck | 14,2734 |
BRN | 636626 |
pKa | 2.38±0.20(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,Room temperature |
Refractive Index | 1.4827 (estimate) |
MDL | MFCD00001381 |
In vitro study | Cycloleucine (4-40 mM; 3 h) blocks internal methylation of viral RNA in B77 transformed chick embryo fibroblasts. Cycloleucine (40 mM; 24 h) blocks the formation of both m 6 A and the penultimate G m in B77 38S RNA subunits by greater than 90%. Cytostatic (10 µg/mL) inhibits the viability human KB and mouse L1210s leukemia cell lines. |
Risk Codes | 22 - Harmful if swallowed |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. |
UN IDs | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS | GY2625000 |
TSCA | Yes |
HS Code | 29224999 |
Hazard Class | 6.1 |
Packing Group | III |
Toxicity | LD50 oral in rat: 290mg/kg |
NIST chemical information | Information provided by: webbook.nist.gov (external link) |
EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
Biological activity | Cycloleucine is a specific inhibitor of S-adenosylmethionine-mediated methylation. Cycloleucine is an antagonist of the glycine allosteric site of the NMDA receptor with a Ki value of 600 μM. Cycloleucine is also a competitive inhibitor of ATP:L-methionine-S-adenosyltransferase in vitro. Cycloleucine has anti-anxiety and cell inhibitory effects. |
target | Ki: 600 μM (NMDA) |
Animal Model: | Male rats bilaterally cannulated into the nucleus accumbens septi (NAS) |
Dosage: | 1 µL of 0.5, 1.0, 2.0, 4 µg/µL |
Administration: | Intracerebroventrical injection |
Result: | Increased time spent in the open arms and extreme arrivals at all doses. Increased open arm entries at the dose of 4 μg. |
category | toxic substances |
toxicity classification | highly toxic |
acute toxicity | oral-rat LD50: 290 mg/kg; Oral-mouse LD50: 119 mg/kg |
flammability hazard characteristics | combustible; combustion produces toxic nitrogen oxide smoke |
storage and transportation characteristics | warehouse ventilation and low temperature drying |
fire extinguishing agent | dry powder, foam, sand, carbon dioxide, mist water |
toxic substance data | information provided by: pubchem.ncbi.nlm.nih.gov (external link) |